SCHEMBL7316262

SCHEMBL7316262

CCN(CC)CCCOc1ccc(C[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C)cc2)C(=O)OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.54
FKBP1A P62942 3/20 0.48
KMT2A Q03164 2/20 0.47
ITGB1 P05556 2/20 0.46
ITGA5 P08648 2/20 0.46
KCNQ1 P51787 2/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
MMP1 P03956 1/20 0.44
ADAM17 P78536 1/20 0.44
HCRTR1 O43613 3/20 0.44
HCRTR2 O43614 3/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP3A4 P08684 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7318203 0.93 ITGA4 (0.60) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7319464 0.92 ITGA4 (0.53) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7322201 0.89 ITGA4 (0.60) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7320958 0.88 ITGA4 (0.51) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7316372 0.88 ITGA4 (0.52) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL6709426 0.87 ITGA4 (0.52) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7327511 0.87 ITGA4 (0.58) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7445241 0.86 ITGA4 (0.53) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7318497 0.86 ITGA4 (0.59) ITGA4FKBP1AKMT2AITGB1ITGA5
SCHEMBL7317569 0.86 ITGA4 (0.58) ITGA4FKBP1AKMT2AITGB1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed